Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST SKIN CANCERS CONTENT
Considering the Changing Treatment Landscape for Patients With Melanoma
Oncologists Experience Improved Survival in Patients With Melanoma
Relatlimab/Nivolumab in Melanoma Improves Brain Metastasis–Free Survival
Tawbi Discusses the Role of Brain Metastases and PD-L1 Status in Melanoma
Nivolumab Combinations Debated for a Patient With Metastatic Melanoma
Management of Immune-Related Toxicities in Melanoma Has Improved Over Time
The Significance of Nivolumab Plus Relatlimab for Advanced Melanoma
CASE-BASED ROUNDTABLES
Advertisement
Advertisement
